Serina Therapeutics, Inc. Common Stock SER 深 滬
等待開盤 09-10 09:30:00 美东时间
5.36
+0.180
+3.47%
華盛通- 最 高5.36
- 今 開5.0679
- 成交量 11.51万股
- 最 低 5.01
- 昨 收 5.18
- 總市值 5342.53万
- 52周最高 10.28
- 市盈率 靜 --
- 換手率 1.15%
- 52周最低 3.81
- 委 比 -50.00%
- 總股本 996.74万
- 歷史最高 209.2615
- 量 比 2.02
- 振 幅 6.76%
- 歷史最低 4.10
- 每 手 1
- 風險率 0.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Strategic Energy Resources Advances Exploration at Canobie Project
The latest update is out from Strategic Energy Resources Limited ( ($AU:SER) )....
今天 09:27
Serina Therapeutics Secures $20M for Parkinson’s Trial
Serina Therapeutics ( ($SER) ) has issued an announcement. On September 9, 2025...
今天 03:47
Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
Serina Therapeutics has secured up to $20 million in financing to advance its SER-252 program for advanced Parkinson’s disease. The funding, led by Board Director Greg Bailey, MD, includes warrants worth an additional $20 million. The financing is structured to provide flexibility in funding as the company progresses its Phase 1b clinical study under the 505(b)(2) NDA pathway. Key milestones include patient enrollment and dosing across cohorts, w...
09-09 19:20
Seres Therapeutics soars on report of takeover offer
Seres Therapeutics jumped 21% in premarket trading after a report that Nestle made a takeover offer of ~$760 million for the company. The $41 a share all-cash offer was valid until the end of August,...
09-08 21:04
Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Serina Therapeutics的首席执行官Steve Ledger将在2025年9月8日参加H.C. Wainwright第27届年会，并在会上介绍公司及其POZ药物优化平台技术。Serina是一家临床阶段的生物技术公司，专注于开发治疗神经疾病和其他适应症的药物。会议直播可通过指定链接观看，回放将持续90天。
09-08 10:00
Seri Industrial S.p.A. Announces Strategic Share Transaction
The latest announcement is out from Seri Industrial S.p.A. ( ($IT:SERI) ). Seri...
09-06 04:02
Wave Life Sciences Announces Data From 200 Mg Single And Multidose And 400 Mg Single Dose Cohorts Of Ongoing Phase 1b/2a Restoraation-2 Study Evaluating WVE-006 As Treatment For AATD
Achieved durable production of serum AAT protein at levels associated with a lower risk of AATD liver and lung diseases following repeat 200 mg doses of WVE-006 (11.9 µM total AAT, 7.2 µM M-AAT) First-ever
09-03 19:32
Strategy acquires 4,048 bitcoins for $449.3M last week
Strategy (NASDAQ:MSTR) bought 4,048 bitcoins (BTC-USD) for an aggregate purchase price of $449.3M during the period between August 26 to Sept. 1, 2025. As of Sept. 1, 2025, the company held 636,505 bi...
09-02 20:17
腾讯开源智能体新框架：不用训练无需充值，用开源模型实现SOTA Agent
腾讯优图实验室 投稿 量子位 | 公众号 QbitAI 智能体（Agent）正成为大模型落地的关键载体。无论是研究探索还是实际应用，高效、易用、可复现的智能体框...
09-02 12:13
英伟达迎来一群劲敌
原标题：英伟达迎来一群劲敌 近期发布的超以太网（Ultra Ethernet，简称UE）1.0规范，为未来人工智能（AI）和高性能计算（HPC）系统定义了一套...
09-01 16:17
